XML 106 R91.htm IDEA: XBRL DOCUMENT v3.20.2
Stockholders' Equity (SARs Activity) (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Aug. 31, 2020
Aug. 31, 2019
SARS Outstanding    
SARS canceled (in shares) (601)  
SARs    
SARS Outstanding    
SARS Outstanding as of beginning of period (in shares) 123,501  
SARS canceled (in shares) (601)  
SARS exercised (in shares) (107,900)  
SARS Outstanding as of end of period (in shares) 15,000 123,501
Aggregate intrinsic value, Outstanding $ 235 $ 1,278
Weighted- Average Exercise Price    
Weighted-Average Exercise Price, Outstanding as of beginning of period (in dollars per share) $ 18.46  
Weighted-Average Exercise Price, SARS canceled (in dollars per share) 14.88  
Weighted-Average Exercise Price, SARS exercised (in dollars per share) 18.48  
Weighted-Average Exercise Price, Outstanding as of end of period (in dollars per share) $ 18.49 $ 18.46
Weighted- Average Remaining Contractual Life, Outstanding (in years) 1 year 1 month 17 days 2 years 1 month 9 days